🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is a registrational Phase III, randomized, open-label, multicent...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-06-29
Trial ID
NCT07582315
This study is being done to find out how effective a new treatment strategy...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2008-08
Trial ID
NCT00737438
Treatments Being Tested
This is a single-arm, single-center feasibility trial of patients with bord...
Status
Recruiting
Location
Juravinski Hospital
Start Date
2021-03-01
Trial ID
NCT04452461
Treatments Being Tested
The aim of this study is to evaluate the synergistic anti-tumor effect of C...
Status
Unknown
Location
Jiege Huo
Start Date
2015-06
Trial ID
NCT02510118
Treatments Being Tested
The goal of this clinical trial is to learn if histotripsy plus chemotherap...
Status
Recruiting
Location
Cleveland Clinic, Case Comprehensive Cancer Center
Start Date
2025-06-30
Trial ID
NCT07044362
Treatments Being Tested
This clinical trial tests how well dynamic contrast enhanced magnetic reson...
Status
Not Yet Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-09-01
Trial ID
NCT07705919
The goal of this clinical trial is to compare in newly diagnosed patients w...
Status
Completed
Location
Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
Start Date
2022-10-01
Trial ID
NCT06048146
This study is being conducted in order determine whether IMA910 as single a...
Status
Completed
Location
Medische Oncologie, Imeldaziekenhuis
Start Date
2008-06
Trial ID
NCT00785122
Treatments Being Tested
Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2022-08-31
Trial ID
NCT05132504
Treatments Being Tested
This is a multicenter, randomized, controlled phase III trial to evaluate t...
Status
Suspended
Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Start Date
2023-12-01
Trial ID
NCT06246344